- Approval Id
- b223e695c09781d6
- Drug Name
- INDIGO CARMINE INJECTION 20 mg/5 ml
- Product Name
- INDIGO CARMINE INJECTION 20 mg/5 ml
- Approval Number
- SIN11374P
- Approval Date
- 2000-08-16
- Registrant
- PHEBRA (SE ASIA) PTE. LTD.
- Licence Holder
- PHEBRA (SE ASIA) PTE. LTD.
- Drug Type
- Therapeutic
- Forensic Classification
- Prescription Only
- Dosage Form
- INJECTION
- Dosage
- <p><strong>Dosage and Administration</strong><br>
Indigo Carmine Injection should be administered by intravenous injection. The recommended amount of indigo carmine to be administered to adults is 20 to 40 mg. Indigo carmine should appear in the bladder within 10 to 15 minutes.</p>
- Route Of Administration
- INTRAVENOUS, INTRAMUSCULAR
- Indication Info
- <p><strong>Indications</strong><br>
Indigo Carmine Injection is used to localise ureteral orifices during cytoscopy and ureteral catheterisation, and as a marker to identify severed ureters and fistulous communications.</p>
- Contraindications
- <p><strong>Contraindications</strong><br>
Indigo Carmine Injection is contraindicated in patients who have known hypersensitivity to the drug or synthetic dyes.</p>
- Atc Code
- V04CH02
- Atc Item Name
- indigo carmine
- Pharma Manufacturer Name
- PHEBRA (SE ASIA) PTE. LTD.
